WDR5-IN-7
WDR5-IN-7 (Compound 22) is an orally bioavailable benzoxazepinone-based WD repeat domain 5 (WDR5) inhibitor. WDR5-IN-7 can be used for the research of anti-cancer[1].
Product Specifications
CAS Number
3032761-31-9
UNSPSC
12352005
Target
WDR5
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/wdr5-in-7.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(OCCN1[C@@H]3C4=CC(OC)=CN=C4CCC3)C(C5=CN(C)N=C5C(F)(F)F)=CC(CN6C=NC=C6)=C2
Molecular Formula
C28H27F3N6O3
Molecular Weight
552.55
References & Citations
[1]Teuscher KB, et al. Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors. J Med Chem. 2023 Dec 12.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
125393-APC 100 µL
CSF1 (Macrophage Colony-stimulating Factor 1, CSF-1, M-CSF, MCSF, Lanimostim) (APC)
Sign In for Pricing
View Details 